Insights Provided by Depression Screening Regarding Pain, Anxiety, and Substance use in a Veteran Population.


Journal

Journal of primary care & community health
ISSN: 2150-1327
Titre abrégé: J Prim Care Community Health
Pays: United States
ID NLM: 101518419

Informations de publication

Date de publication:
Historique:
entrez: 11 8 2020
pubmed: 11 8 2020
medline: 25 6 2021
Statut: ppublish

Résumé

We sought to quantify the extent to which a depression screening instrument commonly used in primary care settings provides additional information regarding pain interference symptoms, anxiety, and substance use. Veterans Aging Cohort Study (VACS) data collected from 2003 through 2015 was used to calculate odds ratios (OR) for associations between positive depression screening result cutoffs and clustering conditions. We assessed the test performance characteristics (likelihood ratio value, positive predictive value, and the percentage of individuals correctly classified) of a positive Patient Health Questionnaire (PHQ-9 & PHQ-2) depression screen for the identification of pain interference symptoms, anxiety, and substance use. A total 7731 participants were included in the analyses. The median age was 50 years. The PHQ-9 threshold of ≥20 was strongly associated with pain interference symptoms (OR 21.6, 95% CI 17.5-26.7) and anxiety (OR 72.1, 95% CI 52.8-99.0) and yielded likelihood ratio values of 7.5 for pain interference symptoms and 21.8 for anxiety and positive predictive values (PPV) of 84% and 95%, respectively. A PHQ-9 score of ≥10 still showed significant associations with pain interference symptoms (OR 6.1, 95% CI 5.4-6.9) and symptoms of anxiety (OR 11.3, 95% CI 9.7-13.1) and yet yielded lower likelihood ratio values (4.36 & 8.24, respectively). The PHQ-9 was less strongly associated with various forms of substance use. Depression screening provides substantial additional information regarding the likelihood of pain interference symptoms and anxiety and should trigger diagnostic assessments for these other conditions.

Identifiants

pubmed: 32772883
doi: 10.1177/2150132720949123
pmc: PMC7418233
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2150132720949123

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR002245
Pays : United States
Organisme : NIAAA NIH HHS
ID : K01 AA029042
Pays : United States
Organisme : NIDA NIH HHS
ID : P30 DA011041
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA024706
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020790
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020799
Pays : United States

Références

Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Br J Psychiatry. 2010 Feb;196(2):92-5
pubmed: 20118450
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Stat Med. 1999 Feb 28;18(4):411-22
pubmed: 10070683
Chonnam Med J. 2015 Apr;51(1):8-18
pubmed: 25914875
Psychol Aging. 2019 Jun;34(4):467-474
pubmed: 30816736
Soc Sci Med. 2009 Oct;69(8):1220-7
pubmed: 19699572
Open Forum Infect Dis. 2019 May 16;6(6):ofz188
pubmed: 31211153
Alcohol Clin Exp Res. 2005 Nov;29(11):2001-7
pubmed: 16340457
Ann Fam Med. 2010 Jul-Aug;8(4):348-53
pubmed: 20644190
Drugs. 2006;66(6):769-89
pubmed: 16706551
Spine J. 2016 Jan 1;16(1):105-16
pubmed: 26523965
J Affect Disord. 2009 Dec;119(1-3):52-8
pubmed: 19361865
J Pain. 2015 Aug;16(8):769-80
pubmed: 26028573
Alcohol Alcohol. 2005 Nov-Dec;40(6):575-7
pubmed: 16115823
Alcohol Res. 2012;34(4):414-31
pubmed: 23584108
J Gen Intern Med. 2006 Sep;21(9):966-72
pubmed: 16918743
Pain Res Manag. 2018 Feb 25;2018:6358624
pubmed: 29682130
JAMA Netw Open. 2020 Mar 2;3(3):e200895
pubmed: 32163167
Int J Epidemiol. 1986 Jun;15(2):176-82
pubmed: 3721679
BMC Psychiatry. 2014 Jun 25;14:187
pubmed: 24965597
JAMA. 2014 Jul 2;312(1):78-84
pubmed: 25058220
Arch Gen Psychiatry. 2011 Jan;68(1):90-100
pubmed: 21199968
AIDS Patient Care STDS. 2012 Jun;26(6):312-9
pubmed: 22612469
Med Care. 2006 Aug;44(8 Suppl 2):S13-24
pubmed: 16849964
CMAJ. 2012 Feb 21;184(3):E191-6
pubmed: 22184363
Int J Nurs Stud. 2002 Jul;39(5):563-72
pubmed: 11996877
Br J Pain. 2013 May;7(2):79-84
pubmed: 26516504
J Adv Nurs. 1989 Apr;14(4):291-7
pubmed: 2738227
J Clin Epidemiol. 2001 Dec;54 Suppl 1:S77-90
pubmed: 11750213
J Affect Disord. 2004 Jan;78(1):49-55
pubmed: 14672796
Headache. 1994 Jul-Aug;34(7):387-93
pubmed: 7928322
Med Sci Sports Exerc. 2000 Nov;32(11):1820-4
pubmed: 11079509
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
J Subst Abuse Treat. 2016 Jan;60:27-35
pubmed: 26297322
Curr Opin Psychiatry. 2008 Jan;21(1):14-8
pubmed: 18281835
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Headache. 2016 May;56(5):821-834
pubmed: 27143127
Lancet. 2009 Aug 22;374(9690):609-19
pubmed: 19640579
J Affect Disord. 2007 Feb;98(1-2):29-43
pubmed: 16952399
Am J Med. 2005 Apr;118(4):330-41
pubmed: 15808128
Arch Gen Psychiatry. 1994 Jan;51(1):8-19
pubmed: 8279933
Am J Med. 1996 Nov;101(5):526-33
pubmed: 8948277
Addiction. 2011 May;106(5):906-14
pubmed: 21382111
Sports Health. 2016 Nov;8(6):507-513
pubmed: 27789871
JAMA. 2016 Jan 26;315(4):380-7
pubmed: 26813211
N Engl J Med. 2005 Feb 10;352(6):596-607
pubmed: 15703424
J Gen Psychol. 1998 Apr;125(2):175-91
pubmed: 9935342
Med Clin North Am. 2014 Sep;98(5):1007-23
pubmed: 25134870
Nicotine Tob Res. 2017 Jan;19(1):3-13
pubmed: 27199385
J Rehabil Res Dev. 2003 Sep-Oct;40(5):381-95
pubmed: 15080223
Arch Intern Med. 2003 Nov 10;163(20):2433-45
pubmed: 14609780
J Clin Epidemiol. 1991;44(7):701-13
pubmed: 2066748
JAMA Psychiatry. 2017 Sep 1;74(9):911-923
pubmed: 28793133
Addict Sci Clin Pract. 2012 Aug 16;7:13
pubmed: 23186254
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Pain. 2016 Sep;157(9):1836-50
pubmed: 27058676

Auteurs

Elizabeth R Stevens (ER)

NYU School of Medicine, New York, NY, USA.

Medha Mazumdar (M)

NYU School of Medicine, New York, NY, USA.

Ellen C Caniglia (EC)

NYU School of Medicine, New York, NY, USA.

Maria R Khan (MR)

NYU School of Medicine, New York, NY, USA.

Kailyn E Young (KE)

NYU School of Medicine, New York, NY, USA.

E Jennifer Edelman (EJ)

Yale School of Medicine, New haven, CT, USA.

Adam J Gordon (AJ)

VA Salt Lake City, Salt Lake City, UT, USA.

David A Fiellin (DA)

Yale School of Medicine, New haven, CT, USA.

Stephen A Maisto (SA)

Syracuse University, Syracuse, NY, USA.

Natalie E Chichetto (NE)

Vanderbilt University School of Medicine, Nashville, TN, USA.

Stephan Crystal (S)

Rutgers School of Social Work, New Brunswick, NJ, USA.

Julie R Gaither (JR)

Yale School of Medicine, New haven, CT, USA.

Amy C Justice (AC)

Yale School of Medicine, New haven, CT, USA.

R Scott Braithwaite (RS)

NYU School of Medicine, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH